Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA panel approves rival to Teva's Plan contraceptive B
Globes, Israel
Sunday, June 20, 2010 - 11:26am
tags:
FDA, Teva Pharmaceuticals, Plan B contraceptive, ellaOne
Pfizer Faces Trials in 200 Suits Over Hormone-Drugs
Bloomberg
Sunday, June 20, 2010 - 11:23am
tags:
lawsuits, Pfizer, Wyeth, Prempro, HRT
Life Sciences Companies Capture the Cash
Seeking Alpha
Sunday, June 20, 2010 - 11:21am
tags:
Abbott Laboratories, Aeterna Zentaris, Bayer, Celsion, Cytori, Genzyme, Discovery Labs, GTC Biotherapeutics, Gen-Probe, Neurocrine, Pharmacyclics, Teva Pharmaceuticals, ProUroCare, SafeStitch Medical
Cypress Bioscience In-Licenses BioLineRx's Novel Antipsychotic
Yahoo
Sunday, June 20, 2010 - 11:17am
tags:
licensing, Cypress Bioscience, BioLineRx, antipsychotics
King Pharmaceuticals: Looking Ahead to the June 2010 Quarter
Seeking Alpha
Sunday, June 20, 2010 - 11:14am
tags:
King
Choose China Pharmaceutical?: China Watch Mail Bag (Video)
The Street
Saturday, June 19, 2010 - 1:06pm
tags:
China Pharmaceutical
Russia to spend $4 bln on pharma industry by 2020
Economic Times, India
Saturday, June 19, 2010 - 1:01pm
tags:
Russia
Global pharma eyes Russia riches with local presence
Money Control
Saturday, June 19, 2010 - 12:58pm
tags:
investors
Amylin Soars on Roche’s Diabetes Delay
Barron's
Saturday, June 19, 2010 - 12:55pm
tags:
Amylin, Roche, type 2 diabetes, Bydureon
Double the Approvals! Double the Fun!
Motley Fool
Saturday, June 19, 2010 - 12:52pm
tags:
Sanofi, Novartis, Dendreon, JNJ, Medivation, Bristol-Myers Squibb, Merck
Adolor shares fall on pain drug study results
Yahoo/AP
Saturday, June 19, 2010 - 12:45pm
tags:
Adolor, ADL5747, ADL5859, pain management
Relational blasts Charles River over WuXi deal
Yahoo/Reuters
Saturday, June 19, 2010 - 12:41pm
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
AstraZeneca to Pay $103 Million to Settle Drug-Pricing Suit
BusinessWeek
Saturday, June 19, 2010 - 12:39pm
tags:
AstraZeneca
New Data from Five Clinical Studies Reinforce RDEA594's Robust Efficacy and Encouraging Safety Profile
PipeLine Review
Saturday, June 19, 2010 - 12:38pm
tags:
hyperuricemia, gout, RDEA594, Ardea
Heavy Call Selling Seen on Amylin Pharma (AMLN)
benzinga
Saturday, June 19, 2010 - 12:32pm
tags:
Amylin, investors
Virtual R&D: Drug Development In The New Millennium
Forbes
Saturday, June 19, 2010 - 11:28am
tags:
R&D
Drugmakers Prodded by FDA for Neglected Disease Drugs
BusinessWeek
Saturday, June 19, 2010 - 11:26am
tags:
Exelixis Announces June 21 Webcast of Conference Call Update on Development Collaboration with Bristol-Myers Squibb Company for XL184
Yahoo/BusinessWire
Saturday, June 19, 2010 - 11:19am
tags:
Exelixis, Bristol-Myers Squibb, XL184, investors
The Shuman Law Firm Investigates Talecris Biotherapeutics Holdings Corp.
Yahoo/BusinessWire
Saturday, June 19, 2010 - 11:16am
tags:
Talecris, Grifols, M&A
Tongjitang Chinese Medicines takes bigger 1Q loss
Yahoo/AP
Saturday, June 19, 2010 - 11:13am
tags:
Tongjitang Chinese Medicines, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.